269 related articles for article (PubMed ID: 24926961)
1. PP2A inhibitors suppress migration and growth of PANC-1 pancreatic cancer cells through inhibition on the Wnt/β-catenin pathway by phosphorylation and degradation of β-catenin.
Wu MY; Xie X; Xu ZK; Xie L; Chen Z; Shou LM; Gong FR; Xie YF; Li W; Tao M
Oncol Rep; 2014 Aug; 32(2):513-22. PubMed ID: 24926961
[TBL] [Abstract][Full Text] [Related]
2. Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell-cycle arrest and apoptosis.
Li W; Xie L; Chen Z; Zhu Y; Sun Y; Miao Y; Xu Z; Han X
Cancer Sci; 2010 May; 101(5):1226-33. PubMed ID: 20331621
[TBL] [Abstract][Full Text] [Related]
3. Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathway.
Li W; Chen Z; Gong FR; Zong Y; Chen K; Li DM; Yin H; Duan WM; Miao Y; Tao M; Han X; Xu ZK
Eur J Cancer; 2011 Nov; 47(17):2654-64. PubMed ID: 21958460
[TBL] [Abstract][Full Text] [Related]
4. Cantharidin and norcantharidin impair stemness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine and erlotinib.
Wang WJ; Wu MY; Shen M; Zhi Q; Liu ZY; Gong FR; Tao M; Li W
Int J Oncol; 2015 Nov; 47(5):1912-22. PubMed ID: 26398277
[TBL] [Abstract][Full Text] [Related]
5. Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA.
Shen M; Wu MY; Chen LP; Zhi Q; Gong FR; Chen K; Li DM; Wu Y; Tao M; Li W
Sci Rep; 2015 Jul; 5():11836. PubMed ID: 26135631
[TBL] [Abstract][Full Text] [Related]
6. PP2A inhibitors induce apoptosis in pancreatic cancer cell line PANC-1 through persistent phosphorylation of IKKα and sustained activation of the NF-κB pathway.
Li W; Chen Z; Zong Y; Gong F; Zhu Y; Zhu Y; Lv J; Zhang J; Xie L; Sun Y; Miao Y; Tao M; Han X; Xu Z
Cancer Lett; 2011 May; 304(2):117-27. PubMed ID: 21376459
[TBL] [Abstract][Full Text] [Related]
7. Pimozide suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling pathway.
Ren Y; Tao J; Jiang Z; Guo D; Tang J
Life Sci; 2018 Sep; 209():267-273. PubMed ID: 30107167
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of p16ink4a regulates the Wnt/β‑catenin signaling pathway in pancreatic cancer cells.
Zhang H; Li X; Meng W; Zhang L; Zhu X; Bai Z; Yan J; Zhou W
Mol Med Rep; 2018 Feb; 17(2):2614-2618. PubMed ID: 29207089
[TBL] [Abstract][Full Text] [Related]
9. Reversion of trichostatin A resistance via inhibition of the Wnt signaling pathway in human pancreatic cancer cells.
Wang B; Zou Q; Sun M; Chen J; Wang T; Bai Y; Chen Z; Chen B; Zhou M
Oncol Rep; 2014 Nov; 32(5):2015-22. PubMed ID: 25224651
[TBL] [Abstract][Full Text] [Related]
10. PR55 alpha, a regulatory subunit of PP2A, specifically regulates PP2A-mediated beta-catenin dephosphorylation.
Zhang W; Yang J; Liu Y; Chen X; Yu T; Jia J; Liu C
J Biol Chem; 2009 Aug; 284(34):22649-56. PubMed ID: 19556239
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
[TBL] [Abstract][Full Text] [Related]
12. Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells.
Jiang S; Zhu L; Tang H; Zhang M; Chen Z; Fei J; Han B; Zou GM
Int J Oncol; 2015 Aug; 47(2):610-20. PubMed ID: 26081414
[TBL] [Abstract][Full Text] [Related]
13. FH535 inhibits proliferation and migration of colorectal cancer cells by regulating CyclinA2 and Claudin1 gene expression.
Tu X; Hong D; Jiang Y; Lou Z; Wang K; Jiang Y; Jin L
Gene; 2019 Mar; 690():48-56. PubMed ID: 30552982
[TBL] [Abstract][Full Text] [Related]
14. Long non‑coding RNA 01614 hyperactivates WNT/β‑catenin signaling to promote pancreatic cancer progression by suppressing GSK‑3β.
Chen LJ; Wu L; Wang W; Zhai LL; Xiang F; Li WB; Tang ZG
Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 35929518
[TBL] [Abstract][Full Text] [Related]
15. Green tea polyphenol EGCG suppresses Wnt/β-catenin signaling by promoting GSK-3β- and PP2A-independent β-catenin phosphorylation/degradation.
Oh S; Gwak J; Park S; Yang CS
Biofactors; 2014; 40(6):586-95. PubMed ID: 25352148
[TBL] [Abstract][Full Text] [Related]
16. Effect of aspirin on the Wnt/beta-catenin pathway is mediated via protein phosphatase 2A.
Bos CL; Kodach LL; van den Brink GR; Diks SH; van Santen MM; Richel DJ; Peppelenbosch MP; Hardwick JC
Oncogene; 2006 Oct; 25(49):6447-56. PubMed ID: 16878161
[TBL] [Abstract][Full Text] [Related]
17. PP2A inhibitors arrest G2/M transition through JNK/Sp1- dependent down-regulation of CDK1 and autophagy-dependent up-regulation of p21.
Gong FR; Wu MY; Shen M; Zhi Q; Xu ZK; Wang R; Wang WJ; Zong Y; Li ZL; Wu Y; Zhou BP; Chen K; Tao M; Li W
Oncotarget; 2015 Jul; 6(21):18469-83. PubMed ID: 26053095
[TBL] [Abstract][Full Text] [Related]
18. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.
Song KS; Jing K; Kim JS; Yun EJ; Shin S; Seo KS; Park JH; Heo JY; Kang JX; Suh KS; Wu T; Park JI; Kweon GR; Yoon WH; Hwang BD; Lim K
Pancreatology; 2011; 11(6):574-84. PubMed ID: 22213040
[TBL] [Abstract][Full Text] [Related]
19. Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer.
Farrell AS; Allen-Petersen B; Daniel CJ; Wang X; Wang Z; Rodriguez S; Impey S; Oddo J; Vitek MP; Lopez C; Christensen DJ; Sheppard B; Sears RC
Mol Cancer Res; 2014 Jun; 12(6):924-39. PubMed ID: 24667985
[TBL] [Abstract][Full Text] [Related]
20. FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis.
Liu L; Zhi Q; Shen M; Gong FR; Zhou BP; Lian L; Shen B; Chen K; Duan W; Wu MY; Tao M; Li W
Oncotarget; 2016 Jul; 7(30):47145-47162. PubMed ID: 27323403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
